ALX ONCOLOGY HOLDINGS INC

For the period ended Jun 30, 2025. Filed Aug 12, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 12, 2025

ALXO$1.11-13.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts)

	June 30,	December 31,
	2025	2024
Assets
Current assets:
Cash and cash equivalents	$19,302	$17,567
Short-term investments	60,012	110,190
Prepaid expenses and other current assets	5,943	6,595
Total current assets	85,257	134,352
Property and equipment, net	1,497	2,905
Long-term investments	4,232	3,524
Other assets	4,334	6,994
Total assets	$95,320	$147,775
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$4,902	$4,497
Payable and accrued liabilities due to related party	40	149
Term loan, current	3,043	435
Accrued expenses and other current liabilities	10,863	13,419
Total current liabilities	18,848	18,500
Term loan, non-current	6,997	9,469
Other non-current liabilities	5,060	6,188
Total liabilities	30,905	34,157
Commitments and contingencies (Note 12)
Stockholders’ equity
Common stock, $0.001 par value; 1,000,000,000 shares authorized as of June 30, 2025 and December 31, 2024; 53,506,777 and 53,052,912 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	54	53
Additional paid-in capital	742,150	734,412
Accumulated other comprehensive income	36	275
Accumulated deficit	(677,825)	(621,122)
Total stockholders’ equity	64,415	113,618
Total liabilities and stockholders’ equity	$95,320	$147,775

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.